Work

Brentuximab Vedotin (SGN-35) Enables Successful Reduced Intensity Allogeneic Hematopoietic Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma

Year: 2011

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood.v118.21.664.664

Authors: Robert W. Chen, Stephen J. Forman, Joycelynne Palmer, Ni-Chun Tsai, Leslie Popplewell, Maria L Delioukina, Torres Alejandra, Bernadette Pulone, Eileen P. Smith, Auayporn P. Nademanee, Chatchada Karanes, Paul O'Donnell, David G. Maloney, Len Farol, Schickwann Tsai, Laurie E. Grove, Ajay K. Gopal

Institutions: City Of Hope National Medical Center, City of Hope, Fred Hutch Cancer Center, University of Utah, Seagen (United States)

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2562843703

FWCI: 1.802

Cites:

Cited by: 9

Related to: 10